Literature DB >> 32140490

The American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma: is it better than the 7th edition?

Dong Woo Shin1, Jaihwan Kim1.   

Abstract

Entities:  

Year:  2020        PMID： 32140490      PMCID： PMC7026799          DOI： 10.21037/hbsn.2019.08.06

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  7 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma.

Authors:  Chen Liu; He Cheng; Kaizhou Jin; Meng Guo; Yu Lu; Zhengshi Wang; Chao Yang; Jiang Long; Quanxing Ni; Xianjun Yu; Guopei Luo
Journal:  Pancreas       Date:  2018-07       Impact factor: 3.327

3.  Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.

Authors:  Sivesh K Kamarajah; William R Burns; Timothy L Frankel; Clifford S Cho; Hari Nathan
Journal:  Ann Surg Oncol       Date:  2017-02-17       Impact factor: 5.344

4.  Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.

Authors:  Peter J Allen; Deborah Kuk; Carlos Fernandez-Del Castillo; Olca Basturk; Christopher L Wolfgang; John L Cameron; Keith D Lillemoe; Cristina R Ferrone; Vicente Morales-Oyarvide; Jin He; Matthew J Weiss; Ralph H Hruban; Mithat Gönen; David S Klimstra; Mari Mino-Kenudson
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

5.  Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.

Authors:  Dong Woo Shin; Jong-Chan Lee; Jaihwan Kim; Sang Myung Woo; Woo Jin Lee; Sung-Sik Han; Sang-Jae Park; Kui Son Choi; Hyo Soung Cha; Yoo-Seok Yoon; Ho-Seong Han; Eun Kyung Hong; Jin-Hyeok Hwang
Journal:  Eur J Surg Oncol       Date:  2019-06-03       Impact factor: 4.424

6.  Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer.

Authors:  Giuseppe Malleo; Laura Maggino; Paola Capelli; Francesco Gulino; Silvia Segattini; Aldo Scarpa; Claudio Bassi; Giovanni Butturini; Roberto Salvia
Journal:  J Am Coll Surg       Date:  2015-02-28       Impact factor: 6.113

7.  Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.

Authors:  Si Shi; Jie Hua; Chen Liang; Qingcai Meng; Dingkong Liang; Jin Xu; Quanxing Ni; Xianjun Yu
Journal:  Ann Surg       Date:  2019-05       Impact factor: 12.969
  7 in total
  3 in total

1.  Metastatic Transition of Pancreatic Ductal Cell Adenocarcinoma Is Accompanied by the Emergence of Pro-Invasive Cancer-Associated Fibroblasts.

Authors:  Shaofei Liu; Yasir Suhail; Ashkan Novin; Lorrie Perpetua
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

2.  A nomogram based on pretreatment levels of serum bilirubin and total bile acid levels predicts survival in colorectal cancer patients.

Authors:  Yinghao Cao; Shenghe Deng; Lizhao Yan; Junnan Gu; Jia Yang; Ming Yang; Li Liu; Kailin Cai
Journal:  BMC Cancer       Date:  2021-01-21       Impact factor: 4.430

Review 3.  Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review.

Authors:  Christina Jane Vellan; Jaime Jacqueline Jayapalan; Boon-Koon Yoong; Azlina Abdul-Aziz; Sarni Mat-Junit; Perumal Subramanian
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.